胶质瘤
医学
中医药
传统医学
药方
佐剂
替代医学
肿瘤科
药理学
病理
癌症研究
作者
Qijia Tan,Jiamin Lu,Jingtong Liang,Yuchen Zhou,Chunrong Yang,Zhiqiang Zhang,Cong Li
出处
期刊:International Review of Neurobiology
日期:2023-01-01
卷期号:: 303-319
标识
DOI:10.1016/bs.irn.2023.07.004
摘要
Glioma is the most common primary central nervous tumor and its malignant and high recurrence rate are seriously threatening patient’s life. The prognosis of glioma patients is still poor with a variety of modern treatments. Traditional Chinese medicine (TCM) is widely used in the adjuvant treatment or alternative medicine of glioma. Curcumae Rhizoma is one of the most commonly used in traditional Chinese medicine prescriptions for its anti-tumor characteristics. There are also many studies that reveals the anti-tumor effect of its active ingredients and some of which have been made into drugs and have been used in clinical practice. This review summarizes the new research progress on Curcumae Rhizoma for the treatment of glioma in recent years.
科研通智能强力驱动
Strongly Powered by AbleSci AI